Want to see AHCO full AI Analyst Report?
Adjusted EBITDA Margin by Segment
Shows profitability efficiency across different business segments, highlighting which areas are driving earnings and where there might be room for improvement.
Respiratory Health remains the margin engine, holding high‑20s/30s margins, while Sleep Health’s margin has eroded into the mid‑teens—a likely consequence of the large capitated rollout, elevated labor and stock‑up CapEx that management says will normalize by Q3. Diabetes and Wellness at Home have collapsed to single‑digit margins, reflecting portfolio dispositions and underperformance; absent operational fixes or clearer ramp benefits from capitated contracts, those segments risk dragging consolidated adjusted EBITDA despite revenue growth and the company’s refinancing giving near‑term flexibility.
AHCO Adjusted EBITDA Margin by Segment
| Date | Sleep Health | Respiratory Health | Diabetes Health | Wellness at Home |
|---|---|---|---|---|
| Jun 30, 2026 | 18.10% | 27.30% | ― | 5.40% |
| Mar 31, 2026 | 17.50% | 28.10% | 2.90% | 3.10% |
| Dec 31, 2025 | 21.90% | 33.80% | 2.60% | 12.50% |
| Sep 30, 2025 | 23.80% | 31.10% | 6.70% | 14.80% |
| Jun 30, 2025 | 24.10% | 28.70% | 3.80% | 13.50% |
| Mar 31, 2025 | 20.10% | 27.50% | 4.60% | 7.90% |
| Dec 31, 2024 | 28.60% | 30.80% | 12.80% | 15.70% |
| Sep 30, 2024 | 25.80% | 28.90% | 5.20% | 13.90% |
| Jun 30, 2024 | 24.30% | 34.90% | 7.10% | 10.90% |
| Mar 31, 2024 | 24.40% | 28.30% | 13.60% | 8.40% |
| Dec 31, 2023 | 30.10% | 32.60% | 11.20% | 16.30% |